46708-214-91 : NDC 2026 Code

46708-214-91 : Amlodipine Besylate And Olmesartran Medoxomil ( Amlodipine Besylate And Olmesartran Medoxomil )

Additionally :

You can get information about “46708-214-91” NDC code in 46708-214-91 in HTML format

HTML | 46708-214-91 in TXT (Plain Text) format

TXT | 46708-214-91 in PDF (Portable Document Format)

PDF | 46708-214-91 in XML format

XML formats.

NDC Code : 46708-214-91 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "46708-214-91",
    "PackageDescription": "1000 TABLET, FILM COATED in 1 BOTTLE (46708-214-91) ",
    "NDC11Code": "46708-0214-91",
    "ProductNDC": "46708-214",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Amlodipine Besylate And Olmesartran Medoxomil",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Amlodipine Besylate And Olmesartran Medoxomil",
    "DosageFormName": "TABLET, FILM COATED",
    "RouteName": "ORAL",
    "StartMarketingDate": "20170718",
    "EndMarketingDate": null,
    "MarketingCategoryName": "ANDA",
    "ApplicationNumber": "ANDA207073",
    "LabelerName": "Alembic Pharmaceuticals Limited",
    "SubstanceName": "AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL",
    "StrengthNumber": "10; 20",
    "StrengthUnit": "mg/1; mg/1",
    "Pharm_Classes": "Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]",
    "DEASchedule": null,
    "Status": "Active",
    "LastUpdate": "2023-01-25",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": "20261231",
    "StartMarketingDatePackage": "20170718",
    "EndMarketingDatePackage": null,
    "SamplePackage": "N"
  }
}